247 related articles for article (PubMed ID: 24696454)
1. Stress-induced cleavage of Myc promotes cancer cell survival.
Conacci-Sorrell M; Ngouenet C; Anderson S; Brabletz T; Eisenman RN
Genes Dev; 2014 Apr; 28(7):689-707. PubMed ID: 24696454
[TBL] [Abstract][Full Text] [Related]
2. MYC-nick promotes cell migration by inducing fascin expression and Cdc42 activation.
Anderson S; Poudel KR; Roh-Johnson M; Brabletz T; Yu M; Borenstein-Auerbach N; Grady WN; Bai J; Moens CB; Eisenman RN; Conacci-Sorrell M
Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5481-90. PubMed ID: 27566402
[TBL] [Abstract][Full Text] [Related]
3. Myc-nick: a cytoplasmic cleavage product of Myc that promotes alpha-tubulin acetylation and cell differentiation.
Conacci-Sorrell M; Ngouenet C; Eisenman RN
Cell; 2010 Aug; 142(3):480-93. PubMed ID: 20691906
[TBL] [Abstract][Full Text] [Related]
4. MYC degradation under low O2 tension promotes survival by evading hypoxia-induced cell death.
Wong WJ; Qiu B; Nakazawa MS; Qing G; Simon MC
Mol Cell Biol; 2013 Sep; 33(17):3494-504. PubMed ID: 23816886
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseases.
Sipos F; Firneisz G; Műzes G
World J Gastroenterol; 2016 Sep; 22(35):7938-50. PubMed ID: 27672289
[TBL] [Abstract][Full Text] [Related]
6. The Role of Nuclear Receptor Subfamily 1 Group H Member 4 (NR1H4) in Colon Cancer Cell Survival through the Regulation of c-Myc Stability.
Lee YJ; Lee EY; Choi BH; Jang H; Myung JK; You HJ
Mol Cells; 2020 May; 43(5):459-468. PubMed ID: 32299194
[TBL] [Abstract][Full Text] [Related]
7. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
[TBL] [Abstract][Full Text] [Related]
8. Modification of the sensitivity to cisplatin with c-myc over-expression or down-regulation in colon cancer cells.
Funato T; Kozawa K; Kaku M; Sasaki T
Anticancer Drugs; 2001 Nov; 12(10):829-34. PubMed ID: 11707650
[TBL] [Abstract][Full Text] [Related]
9. Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer.
Li QQ; Xie YK; Wu Y; Li LL; Liu Y; Miao XB; Liu QZ; Yao KT; Xiao GH
Oncotarget; 2017 Feb; 8(7):12067-12080. PubMed ID: 28076844
[TBL] [Abstract][Full Text] [Related]
10. Myc-driven overgrowth requires unfolded protein response-mediated induction of autophagy and antioxidant responses in Drosophila melanogaster.
Nagy P; Varga A; Pircs K; Hegedűs K; Juhász G
PLoS Genet; 2013; 9(8):e1003664. PubMed ID: 23950728
[TBL] [Abstract][Full Text] [Related]
11. Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors.
Tolani B; Gopalakrishnan R; Punj V; Matta H; Chaudhary PM
Oncogene; 2014 May; 33(22):2928-37. PubMed ID: 23792448
[TBL] [Abstract][Full Text] [Related]
12. Caspase-mediated cleavage of RNA-binding protein HuR regulates c-Myc protein expression after hypoxic stress.
Talwar S; Jin J; Carroll B; Liu A; Gillespie MB; Palanisamy V
J Biol Chem; 2011 Sep; 286(37):32333-43. PubMed ID: 21795698
[TBL] [Abstract][Full Text] [Related]
13. c-Myc is regulated by HIF-2α in chronic hypoxia and influences sensitivity to 5-FU in colon cancer.
Wang L; Xue M; Chung DC
Oncotarget; 2016 Nov; 7(48):78910-78917. PubMed ID: 27793037
[TBL] [Abstract][Full Text] [Related]
14. Brusatol-Mediated Inhibition of c-Myc Increases HIF-1α Degradation and Causes Cell Death in Colorectal Cancer under Hypoxia.
Oh ET; Kim CW; Kim HG; Lee JS; Park HJ
Theranostics; 2017; 7(14):3415-3431. PubMed ID: 28912885
[TBL] [Abstract][Full Text] [Related]
15. MYC promotes tryptophan uptake and metabolism by the kynurenine pathway in colon cancer.
Venkateswaran N; Lafita-Navarro MC; Hao YH; Kilgore JA; Perez-Castro L; Braverman J; Borenstein-Auerbach N; Kim M; Lesner NP; Mishra P; Brabletz T; Shay JW; DeBerardinis RJ; Williams NS; Yilmaz OH; Conacci-Sorrell M
Genes Dev; 2019 Sep; 33(17-18):1236-1251. PubMed ID: 31416966
[TBL] [Abstract][Full Text] [Related]
16. Myc-nick promotes efferocytosis through M2 macrophage polarization during resolution of inflammation.
Zhong X; Lee HN; Kim SH; Park SA; Kim W; Cha YN; Surh YJ
FASEB J; 2018 Oct; 32(10):5312-5325. PubMed ID: 29718706
[TBL] [Abstract][Full Text] [Related]
17. High susceptibility of metastatic cells derived from human prostate and colon cancer cells to TRAIL and sensitization of TRAIL-insensitive primary cells to TRAIL by 4,5-dimethoxy-2-nitrobenzaldehyde.
Kim HB; Kim MJ; Kim DY; Lee JW; Bae JH; Kim DW; Kang CD; Kim SH
Mol Cancer; 2011 Apr; 10():46. PubMed ID: 21513580
[TBL] [Abstract][Full Text] [Related]
18. The c-MYC-ABCB5 axis plays a pivotal role in 5-fluorouracil resistance in human colon cancer cells.
Kugimiya N; Nishimoto A; Hosoyama T; Ueno K; Enoki T; Li TS; Hamano K
J Cell Mol Med; 2015 Jul; 19(7):1569-81. PubMed ID: 25689483
[TBL] [Abstract][Full Text] [Related]
19. IMP-1 displays cross-talk with K-Ras and modulates colon cancer cell survival through the novel proapoptotic protein CYFIP2.
Mongroo PS; Noubissi FK; Cuatrecasas M; Kalabis J; King CE; Johnstone CN; Bowser MJ; Castells A; Spiegelman VS; Rustgi AK
Cancer Res; 2011 Mar; 71(6):2172-82. PubMed ID: 21252116
[TBL] [Abstract][Full Text] [Related]
20. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
Kim J; Roh M; Abdulkadir SA
BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
